[Jefferson] [Hospital] [Jefferson Pulse] [Employment] [Contact Us] [Search] [News]
 
[Home]
[About Us]
[for Faculty]
[for Industry]
[Staff]
[Helpful Links]


Office of Technology Transfer
and Business Development
1020 Locust Street, Suite M34
Philadelphia, PA 19107
(215) 955-6862
Contact us through e-mail

Specific List For "Therapeutic"

Case Number

Title

Non-Confidential Summary

Issued Patent

Lead Inventor's Website

BER_ERI.001

Use of Tempol in the Prevention of Photoaging

 

[US Patent No. 5,840,734]
     

Link

BLO_TIM.002

Glucosidase Inhibitors as a Treatment for Viruses that Bud from the Endoplasmic Reticulum

 

       

 

BRO_JON.001

The Specific Level of Expression and Localization of a Key Signaling Protein Can Dictate And Predict The Response Of The Most Commonly Used Chemotherapeutic Used In The Treatment Against Pancreatic Cancer, Ovarian Cancer And Metastatic Breast Cancer

NCS for BRO_JON.001

       

Link

CON_PAU.001

Use Of Magnetic Particles In The Focal Delivery Of Cells

 

[US Patent No. 6,203,487]
     

 

CRO_CAR.002

Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene

NCS for Croce tumor suppressor techs (CRO 2,4,5,16)

       

 

CRO_CAR.004

The Human FHIT Gene

NCS for Croce tumor suppressor techs (CRO 2,4,5,16)

[United States Patent: 7220834]
[United States Patent: 6774217]
[United States Patent: 6242212]
[United States Patent: 5928884]

 

CRO_CAR.009

TCL-1 Gene And Protein And Related Methods And Compositions

NCS for Croce TCL-1 techs (CRO 9,15)

       

 

CRO_CAR.015

Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression

NCS for Croce TCL-1 techs (CRO 9,15)

       

 

CRO_CAR.016

Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same

NCS for Croce tumor suppressor techs (CRO 2,4,5,16)

       

 

CRO_CAR.017

Role of microRNA Genes In Human Cancer

NCS for Croce miRNA techs (CRO 17, 25)

       

 

CRO_CAR.019

Involvement Of The ALL-1 Gene In A Solid Tumor1

 

[US Patent No. 5,567,586]
     

 

CRO_CAR.025

microRNA genes in cancer diagnosis and treatment

NCS for Croce miRNA techs (CRO 17, 25)

       

 

DAN_REN.003

Targeting of Integration of Retroviral Vectors by Manipulation Integration Cofactors

NCS for DAN_REN.003

       

Link

DIE_BER.010

Recombinant Rabies for Pre- and Post-Exposure Prophylaxis

 

       

Link

FEL_ART.001

Adenosine A1 Receptor Mutations Predict Infarct Size

NCS for FEL_ART 001, 003

       

Link

FEL_ART.003

Use of Adenosine Receptor Subtypes as Therapeutic Targets

NCS for FEL_ART 001, 003

       

Link

HUA_ZIW.001

Small Molecules Inhibitor of BCL-2

HUA_ZIW.001, .006, .011 NCS

[US Patent No. 6,492,389]
     

 

HUA_ZIW.006

Enhancement of Peptide Cellular Uptake

HUA_ZIW.001, .006, .011 NCS

[US Patent No. 6,713,280]
     

 

HUA_ZIW.011

Synthesis of 4-H Chromene Derivatives Compounds that Bind Bcl-2 Protein and Induce Apoptosis in Tumor Cells

HUA_ZIW.001, .006, .011 NCS

[US Patent No. 6,660,871]
     

 

IOZ_REN.001

A Role For Decorin In Tumor Suppression

 

[US Patent No. 6,524,573]
     

Link

IOZ_REN.009

Endorepellin, A Novel Inhibitor of Angiogenesis Derived from the Carboxyl Terminus of Perlecan

NCS for IOZ_REN.009

[US Patent No. 6,821,947]
     

Link

KAS_DAV.001

A Small Bowel Purgative for Wireless Capsule Endoscopy

NCS for KAS_DAV 001

       

 

KMI_ERI.002

Mammalian and Human REC2

 

[US Patent No. 6,410,226]
     

 

KMI_ERI.004

Chimeric Mutation Vectors Having Non-Natural Nucleotides

 

[US Patent No. 5,731,181]
[US Patent No. 5,795,972]
   

 

KMI_ERI.005

Methods for Enhancing Gene Conversion or Genetic Repair by Chimeric Oligonucleotides

 

       

 

KMI_ERI.007

Compositions and Methods to Promote Homologous Recombination in Eukaryotic Cells and Organisms

 

[US Patent No. 5,780,296]
     

 

KMI_ERI.008

Compounds and Methods for Site-Directed Mutations in Eukaryotic Cells

 

[US Patent No. 5,756,325]
     

 

KOC_WAL.001

GRK2 Activity as a Therapeutic Target for Heart Failure

NCS for KOC_WAL.001

       

Link

KOP_HIL.006

Polypeptides Fused with Alfalfa Mosaic Virus or Ilarvirus Capsid Proteins

 

[US Patent No. 6,042,832]
[US Patent No. 6,448,070]
   

Link

KOP_HIL.021

Generation of Plant-Based Recombinant Subunit Vaccine Against Smallpox

NCS for KOP_HIL.021

       

Link

KWO_SIM.001

Novel Tumor Suppressor Encoding Nucleic Acid, PTX1, and Methods of Use Thereof

NCS for KWO_SIM.001

[US Patent No. 6,743,603]
     

 

LI_ZHI.U001

Human Serum Albumin-based Drug Delivery and Targeting System

NCS for LI_ZHI.U001

       

 

MEN_SUE.002

Cell Migration Leading to Posterior Capsule Opacification can be Prevented by Inhibition of Src Kinase Activities

NCS for MEN_SUE.002

       

Link

OST_JEW.002

Intra-Peritoneal Perfusion of Oxygenated Fluorocarbons

 

[US Patent No. 4,657,532]
[US Patent No. 4,963,130]
   

Link

PAC_MAU.005

Prevention and Treatment of Abnormal Ossification and Mineralization

NCS for PAC_MAU.005

       

 

PES_CES.001

Compositions And Methods For Use In Affecting Hematopoietic Stem Cell Populations In Mammals

 

[US Patent No. 6,586,192]
     

 

PES_RIC.003

A New Breast Cancer Suppressor: MicroRNA 17/20

NCS for PES_RIC.003

       

 

RAB_JOS.001

Development of an Enhancer/Promoter Pair for Heart Selective Gene Expression

NCS for RAB_JOS.001

       

Link

SAN_JAM.001

Peptides with High Affinity for Heparin and for Proteoglycans to be used to Promote Endothelialization of Synthetic Vascular Graft Surfaces, or to Target the Delivery of Drugs to Cell Surfaces

NCS for SAN_JAM.001, .002

[US Patent No. 6,855,801]
     

Link

SAN_JAM.002

Peptides that Neutralize Heparin or Proteoglycans, or Promote Cell Adhesion or Drug Delivery

NCS for SAN_JAM.001, .002

[US Patent No. 7,259,140]
     

Link

SAN_JAM.003

Novel Method to Rapidly Promote Angiogenesis

NCS for SAN_JAM.003

       

Link

SCH_JAY.001

Treatment of Parkinson's Disease with Oligonucleotide and Triplex Technology

NCS for SCH_JAY.001 and SCH_JAY.002

       

Link

SCH_JAY.002

Partial Agonists at the Glycine Modulatory Site of the NMDA Receptor for Treating Cognitive Dysfunction in Parkinson's Disease

NCS for SCH_JAY.001 and SCH_JAY.002

       

Link

SCH_JAY.004

Method of Treating Parkinson's Disease and Composition for the Same

NCS for SCH_JAY.004

[United States Patent: 7160913]
     

Link

SHA_KUM.013

Treatment of kidney disease with the Hormone Adiponectin

NCS for SHA_KUM.013

       

 

SIM_LAN.004

A Vaccine Against Botulinum that Does Not Bind to the Nervous System

NCS for SIM_LAN.004

       

Link

STR_DAV.001

SV40 Viral Vectors for Targeted Integration Into Cells

 

[US Patent No. 5,863,794]
     

Link

SUN_XIA.001

Implantable Sensor and System for Measurement and Control of Blood Constituent Levels

 

[US Patent No. 5,995,860]
[US Patent No. 6,122,536]
   

 

SYK_YUR.004

Invention of a Novel Serum Free Media for Cultivation of Hybridoma Cells to Achieve Production of Highly Homogenous Monoclonal Antibodies (MAb) in Preparative Scale

 

       

Link

THA_MAT.002

Lipid soluble radioactive metal chelates for tumor therapy

NCS for THA_MAT.002

[US Patent No. 6,685,913]
     

Link

THO_JEF.001

Nitric Oxide Donor Compositions, Methods, Apparatus, and Kits for Alleviating Vasoconstriction and Vasospasm in a Mammal

 

[US Patent No. 6,358,536]
     

 

ZAL_AND.002

Inhibition Of Extracellular Matrix Synthesis By Antisense Compounds Directed To Nuclear Proto-Oncogenes

 

[US Patent No. 6,133,242]
     

 

 

 

For further information, please contact Lisa Lau (lisa.lau@jefferson.edu) or Debbie Wang (debbie.wang@jefferson.edu) at 215-955-6862.

Content maintained by Joy Tsai.
Copyright © Thomas Jefferson University. All Rights Reserved.

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff. Please read our Privacy Statement.

Thomas Jefferson University | Jefferson Medical College | Jefferson College of Graduate Studies | Jefferson College of Health ProfessionsJefferson Pulse